其他
$Regencell Bioscience(RGCB)$ CERT Certification by an exchange approving securities for listing Accession Number: 0001354457-21-000798 Act: 34 Size: 583 KB 网页链接
脑再生科技有限公司的EARTH有效性试验显示,其试验中RGC-COV19™液体方剂可以在6天疗程中有效清除入组患者的COVID-19轻至中度症状
在该试验的37例COVID-19受治患者中,36例(约97.3%)诉称,除味觉和嗅觉丧失或减退(“感觉功能障碍”)和偶发咳嗽外,其...查看全文
$Regencell Bioscience(RGCB)$ CERT Certification by an exchange approving securities for listing Accession Number: 0001354457-21-000798 Act: 34 Size: 583 KB 网页链接
$Regencell Bioscience(RGCB)$ 8-A12B Registration of securities [Section 12(b)] Accession Number: 0001213900-21-036964 Act: 34 Size: 15 KB 网页链接
$Regencell Bioscience(RGCB)$ FWP Filing under Securities Act Rules 163/433 of free writing prospectuses Accession Number: 0001213900-21-036122 Act: 34 Size: 5 MB 网页链接
$Regencell Bioscience(RGCB)$ FWP Filing under Securities Act Rules 163/433 of free writing prospectuses Accession Number: 0001213900-21-034934 Act: 34 Size: 5 MB 网页链接
$Regencell Bioscience(RGCB)$ F-1/A [Amend] Registration statement for certain foreign private issuers Accession Number: 0001213900-21-033616 Act: 33 Size: 2 MB 网页链接
$Regencell Bioscience(RGCB)$ F-1/A [Amend] Registration statement for certain foreign private issuers Accession Number: 0001213900-21-032158 Act: 33 Size: 3 MB 网页链接
$Regencell Bioscience(RGCB)$ F-1/A [Amend] Registration statement for certain foreign private issuers Accession Number: 0001213900-21-022860 Act: 33 Size: 2 MB 网页链接